Original Article
Impact of Coronavirus Disease 2019 (COVID-19) on the Practice of Clinical Radiology

https://doi.org/10.1016/j.jacr.2020.07.002Get rights and content

Abstract

The speed at which coronavirus disease 2019 (COVID-19) spread quickly fractured the radiology practice model in ways that were never considered. In March 2020, most practices saw an unprecedented drop in their volume of greater than 50%. The profound changes that have interrupted the arc of the radiology narrative may substantially dictate how health care and radiology services are delivered in the future. We examine the impact of COVID-19 on the future of radiology practice across the following domains: employment, compensation, and practice structure; location and hours of work; workplace environment and safety; activities beyond the “usual scope” of radiology practice; and CME, national meetings, and professional organizations. Our purpose is to share ideas that can help inform adaptive planning.

Key Words

Clinical practice
COVID-19
radiologist

Cited by (0)

Dr Rosen is on the scientific advisory boards of LungLife AI, Parexel, and Canon Medical Systems, outside the submitted work. He has received payments from Parexel and Canon Medical Systems, and stock options from LungLife AI. Dr Norbash is a scientific advisor for GE, Siemens, Pneumbra, Stryker, IBM, and cofounder and stockholder of Boston Imaging Core Laboratories, outside the submitted work. Dr Kruskal is an author for Up-To-Date, Inc. Dr Meltzer is a board member of RSNA. Dr Yee reports grants from Echopixel, Philips, and GE Healthcare US, outside the submitted work. Dr Thrall states that he has no conflict of interest related to the material discussed in this article. Dr Rosen, Dr Norbash, Dr Kruskal, Dr Meltzer, Dr Yee, and Dr Thrall are nonpartner, non–partnership track employees.

View Abstract
© 2020 Published by Elsevier Inc. on behalf of American College of Radiology